Zeuzem, Stefan <br/><br/>
Grazoprevir-Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection: A Randomized Trial.  [electronic resource] 

 -  Annals of internal medicine  Jul 2015 
 - 1-13 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1539-3704 
<br/><br/><label>Standard No.: </label>10.7326/M15-0785  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Amides<br/>Antiviral Agents--adverse effects<br/>Benzofurans--adverse effects<br/>Carbamates<br/>Cyclopropanes<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Fatigue--chemically induced<br/>Female<br/>Genotype<br/>Headache--chemically induced<br/>Hepacivirus--genetics<br/>Hepatitis C, Chronic--complications<br/>Humans<br/>Imidazoles--adverse effects<br/>Liver Cirrhosis--complications<br/>Male<br/>Middle Aged<br/>Nausea--chemically induced<br/>Quinoxalines--adverse effects<br/>Sulfonamides<br/>Treatment Outcome<br/>Viral Load<br/>Young Adult